Record revenue and margin expansion driven by AI data center optical connectivity demand.

AI infrastructure orders hit $4 billion in quarter, driving record fiscal year results.

Advanced Computing surged to record 31% of the Computing segment amid AI and server demand.

Revenue fell 11.3% as Movies divestiture and weak renewals pressured results.

Data center revenue projected to exceed $65 million for full year 2026.

IPO proceeds boost cash to $288.7M as company advances toward 2028 production restart.

Medical device revenue surged 36% as backlog climbed 25.8% year over year.

Revenue declined 15% year-over-year, but net losses narrowed significantly.

Service revenue grew 10.3% as management targets hyperscale data center operators.

Japan regulatory progress and narrowed losses drive CardiAMP advancement.

Revenue fell 23% as demand-side platform spending declined sharply.

Security Force integration drove record customer count and positive gross margin.

U.S. revenue surged 20.3% while tariff recoveries boosted margins.

ELPIS II trial data expected September 2026 as cash runway extends into Q4.

Licensing revenue surged 48% as AI training deals accelerated.

Emrosi prescriptions hit 14,000 in July as payer coverage expands and margins improve.

Illinois Medicaid coverage for PreTRM test unlocks 50,000 annual births as payer access expands.

Revenue surged 332% year-over-year as SOL holdings climbed to 7.6 million tokens.

NEPHRO study hits 75% enrollment with data expected by year-end.

CEO Rajavelu discusses $105 million financing and SP001 immunology strategy.

Turnaround gains lift margins as Europe struggles with geopolitical headwinds.

Staffing firm returns to profitability amid margin expansion and strategic review.

Traffic improved to best level since Q1 2023 as refranchising deal nears close.

HCV regimen met non-inferiority with 8-week dosing for non-cirrhotic patients.

Revenue surged 26% as Peru and Colombia markets accelerated with 100% occupancy.